| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Histone-lysine N-methyltransferase SETD2 (SETD2) , partial |
|---|
| Description | MW: 175,982 Da. Purity >85% (SDS-PAGE). Huntington s disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This prot |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [histone-lysine N-methyltransferase SETD2 isoform 1; Histone-lysine N-methyltransferase SETD2; histone-lysine N-methyltransferase SETD2; SET domain containing 2; HIF-1; Huntingtin yeast partner B] |
|---|
| Gene, Accession, CAS # | SETD2, Gene ID: 29072, Accession: NP_054878.5 |
|---|
| Catalog # | MBS1475711 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Histone-lysine N-methyltransferase SETD2 (SETD2) , partial from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|